FDA
-
-
-
-
-
-
-
Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
-
-
-
-
-
-
-
Masimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 Guidance
-
-
-
-
-
-
-
Masimo to Present in the Jefferies London Healthcare Conference
-
-
-
-
-
-
-
Masimo Partners with March of Dimes to Help Parents with Babies in the NICU Make the Transition from Hospital to Home
-
-
-
-
-
-
-
Masimo W1® Medical Watch Receives FDA 510(k) Clearance for Connectivity to the Masimo SafetyNet® Telemonitoring System
-
-
-
-
-
-
-
Masimo Responds to Politan’s Continuing Misrepresentations
-
-
-
-
-
-
-
Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
-
323,561 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

